Dr. Dena Moskowitz, MD

Dr. Moskowitz practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Moskowitz's NPI, 1790896157, was assigned on August 31, 2006. Dr. Moskowitz graduated from Medical College Of Wisconsin in 2011. Dr. Moskowitz holds California license A122456.

Dr. Moskowitz's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Moskowitz's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Moskowitz is also affiliated with Hoag Hospital Newport Beach. The medical group on file is OB/GYN University Associates. Dmand AI also links Dr. Moskowitz to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moskowitz practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Moskowitz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Moskowitz is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Moskowitz's licenses on file in 2 states: California and Washington.

Dmand AI lists bladder disease, kidney stone disease, pelvic prolapse, urinary endoscopy, urine flow blockage, UTI and vaginal prolapse repair among the conditions Dr. Moskowitz treats.

CMS data shows 12,404 Medicare services from Dr. Moskowitz across 14 procedure codes in 2024, for 515 Medicare patients. Medicare paid $171,300 for them. Every service was in an office.

CMS counts 515 Medicare patients who saw Dr. Moskowitz in 2024. The largest group is 65 to 74, with 208 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moskowitz's median patient age at 66, with 99% women.

In 2024, Dr. Moskowitz wrote 1,162 Medicare Part D claims for 360 patients. 71% of them were for generic drugs. CMS names the drug for 1,090 of them, across 24 drugs with 11 or more claims each, at $317,923 in total drug cost. In 2023, CMS named 1,272 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Moskowitz for performance year 2024, reported through an alternative payment model (APM). Dr. Moskowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moskowitz as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Moskowitz, published from 2015 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Electric Stimulation Therapy, Suburethral Slings and Urinary Incontinence. Dr. Moskowitz has published most often in J Urol. Dr. Moskowitz's most frequent co-authors are Kathleen C. Kobashi, MD, Alvaro Lucioni, MD and Sarah Ashley Adelstein, MD.

Dmand AI links Dr. Moskowitz to 1 clinical trial. Conditions studied include Urinary Incontinence, Urge and Urinary Bladder, Overactive.

CMS Open Payments shows 93 general payments to Dr. Moskowitz from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 87% of the total. Medtronic USA, Inc. paid the most, $3,068.

Dr. Moskowitz graduated from Medical College Of Wisconsin in 2011. Dr. Moskowitz is a member of AUA.

Dr. Moskowitz is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.